| Financial Year |
March 31 2023 |
| Monetary Funds |
137,269,979.76 |
| Held-for-trading Financial Assets |
302,656,038.56 |
| Notes Receivable |
2,946,504.98 |
| Accounts Receivable |
46,222,353.35 |
| Advances to Suppliers |
10,083,740.60 |
| Other Receivables |
2,169,963.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,438,887.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,500,146.35 |
| Total Current Assets |
611,584,304.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,787,552.77 |
| Investment Properties |
15,618,310.47 |
| Fixed Assetes |
126,006,125.43 |
| Under-construction Projects |
130,121,733.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,018,245.13 |
| R&D expenses |
-- |
| Goodwill |
9,132,499.96 |
| Long-Term Deferred and Prepaid Expenses |
2,984,566.93 |
| Deferred Income Tax Assets |
2,951,601.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
328,530,024.91 |
| Total Assets |
940,114,329.20 |
| Short-Term Loans |
5,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,311,888.80 |
| Accounts Payable |
29,732,457.98 |
| Accounts Received In Advance |
853,544.72 |
| Employee Compensation Payable |
4,986,410.00 |
| Taxes Payable |
2,031,484.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,698,515.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,946,536.51 |
| Other Current Liabilities |
1,215,922.42 |
| Sub-Total of Current Liabilities |
88,747,975.62 |
| Long-term Loans |
51,222,558.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,429,173.11 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,110,293.66 |
| Deferred Income Tax Liabilities |
1,305,413.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,433,137.73 |
| Total Liabilities |
155,181,113.35 |
| Paid-In Capital(Or Share Stock) |
64,555,200.00 |
| Capital Surplus |
414,239,505.99 |
| Surplus Reserve |
33,568,762.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
264,903,439.83 |
| Minority Stockholder's Interest |
7,646,014.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
777,287,201.37 |
| Owner's Equity（Stockholder's Equity） |
784,933,215.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
940,114,329.20 |
